MXPA02010725A - Ensayo serologico para neospora caninum. - Google Patents

Ensayo serologico para neospora caninum.

Info

Publication number
MXPA02010725A
MXPA02010725A MXPA02010725A MXPA02010725A MXPA02010725A MX PA02010725 A MXPA02010725 A MX PA02010725A MX PA02010725 A MXPA02010725 A MX PA02010725A MX PA02010725 A MXPA02010725 A MX PA02010725A MX PA02010725 A MXPA02010725 A MX PA02010725A
Authority
MX
Mexico
Prior art keywords
protein
caninum
neospora caninum
fusion protein
serological assay
Prior art date
Application number
MXPA02010725A
Other languages
English (en)
Inventor
Dianne Marie Ritter
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA02010725A publication Critical patent/MXPA02010725A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/45Toxoplasma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion se refiere a la deteccion serologica de animales vacunados frente a Neospora caninum mediante la reaccion del suero de un sujeto con una proteina reactiva frente a N. caninum. La proteina puede ser una proteina completa nativa o recombinante de bradizoito de N. caninum o de Toxoplasma gondii, o una proteina de fusion, o una proteina de fusion truncada o fragmento de las mismas. La proteina puede utilizarse en cualquiera de una serie de ensayos, incluyendo ensayos de inmuno absorcion con enzimas ligadas (ELISA), radioinmunoensayo (RIA), transferencia Western y otras formas adecuadas de inmunoensayo.
MXPA02010725A 2001-10-31 2002-10-30 Ensayo serologico para neospora caninum. MXPA02010725A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33481101P 2001-10-31 2001-10-31

Publications (1)

Publication Number Publication Date
MXPA02010725A true MXPA02010725A (es) 2004-09-03

Family

ID=23308938

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010725A MXPA02010725A (es) 2001-10-31 2002-10-30 Ensayo serologico para neospora caninum.

Country Status (16)

Country Link
US (1) US20050112567A1 (es)
EP (1) EP1308729A3 (es)
JP (1) JP2003166992A (es)
KR (1) KR20040053224A (es)
CN (1) CN1639574A (es)
AR (1) AR037132A1 (es)
BR (1) BR0206320A (es)
CA (1) CA2410134A1 (es)
HU (1) HUP0600049A3 (es)
IL (1) IL160966A0 (es)
MX (1) MXPA02010725A (es)
NZ (1) NZ522276A (es)
PL (1) PL370213A1 (es)
RU (1) RU2277712C2 (es)
WO (1) WO2003038434A2 (es)
ZA (1) ZA200208697B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280597A1 (en) 2003-06-11 2006-12-14 Ishikawajima-Harima Heavy Industries Co., Ltd. Rotating member, housing, bearing, gearbox, rotating machine, shaft structure, and surface treatment method
EP2964565B1 (en) * 2013-03-05 2019-12-04 University Of Washington Through Its Center For Commercialization Western blot analysis using polymer dots

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69729839T2 (de) * 1996-11-12 2005-07-21 Pfizer Inc. Attenuierter lebender Neospora Impfstoff

Also Published As

Publication number Publication date
HUP0600049A2 (en) 2007-05-02
EP1308729A2 (en) 2003-05-07
RU2277712C2 (ru) 2006-06-10
AR037132A1 (es) 2004-10-20
CN1639574A (zh) 2005-07-13
PL370213A1 (en) 2005-05-16
WO2003038434A3 (en) 2003-10-30
ZA200208697B (en) 2004-04-28
US20050112567A1 (en) 2005-05-26
EP1308729A3 (en) 2003-09-17
NZ522276A (en) 2004-03-26
KR20040053224A (ko) 2004-06-23
CA2410134A1 (en) 2003-04-30
HUP0600049A3 (en) 2007-11-28
BR0206320A (pt) 2003-09-09
IL160966A0 (en) 2004-08-31
JP2003166992A (ja) 2003-06-13
RU2004113367A (ru) 2005-03-20
WO2003038434A2 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
Gosling Immunoassays
SI1354204T2 (sl) Hcv antigen antitelo kombinacijska analiza
GB2345964A (en) Assay using porosity-reduction to inhibit migration
CA2506580A1 (en) Assay kit and antibody for human low molecular weight cd14
EP1419384A4 (en) PREGNANCY DETECTION METHOD
ATE349469T1 (de) Kristallisierung von igf-1
CN1979165B (zh) α-胞衬蛋白抗原表位多肽混合物及其应用
MXPA02010725A (es) Ensayo serologico para neospora caninum.
CA2524002A1 (en) Sars-related proteins
WO2001014885A3 (de) Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
Babaie et al. Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli
BR0016458A (pt) Reagentes, métodos e kits para detectar proteìnas de bacillus thuringiensis
EP0804452A4 (en) RECOMBINANT C140 RECEPTOR AND ITS AGONISTS AND ANTAGONISTS
CA2549066A1 (en) Diagnosing acute coronary syndrome by measuring levels of free papp-a
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
BRPI0418084A (pt) método para a preparação de suporte sólido pronto-para-usar para ensaio imunoabsorvente ligado a enzima (elisa) rápido
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
AU4643301A (en) Method for detecting helicobacter pylori and heilmanii in fecal and salivary specimen and biopsy material
EP0271810A3 (en) Immunological determination of free human protein s and c4bp-protein s complex
AU2003301583A8 (en) Ip3 protein binding assay
EP0918218A3 (en) Method for immunological assay
WO2006138694A3 (en) Rabbit monoclonal antibody against id1 protein
WO2007089563A3 (en) Rabbit monoclonal antibodies against mouse/human id3 proteins
WO2004112694A3 (en) Immunogenic reagents from west nile virus
DE60018785D1 (de) Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin